CON Concentra Group Holdings Parent, Inc. Common Stock
NYSE · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 6, 2026
$35.65
· of 52w range
· above low
· to high
$18.5552w low
$36.7152w high
Market Cap (MRQ)
$4.55B
P/E (TTM)
23.0
EPS (TTM)
$1.55
Revenue (TTM)
$2.29B
your badges
52W Range
$19–$37
Analyst Rating
BUY
Price Target
$41
P/E
23.0
ROE
48.5%
Net Profit Margin
8.7%
Your badge strip is empty — pin a metric anywhere on this page.
CON Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$35.65
Market Cap (MRQ)
$4.55B
P/E (TTM)
23.0
EPS (TTM)
$1.55
Revenue (TTM)
$2.29B
Div Yield
0.70%
ROE (TTM)
48.5%
52W Range
$19–$37
CON Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$2.16B2022-12-31 → 2025-12-31
EPS$1.302022-12-31 → 2025-12-31
Free Cash Flow$197M2024-12-31 → 2025-12-31
Net margin8.7%2024-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | CON | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 23.0 | · | 16.5 | Overvalued | |
| P/S (TTM) | 2.0 | · | 1.2 | Overvalued | |
| P/B (MRQ) | 9.5 | · | 3.8 | Overvalued | |
| Price / FCF (TTM) | 17.0 | · | · | · | |
| Price / Cash Flow (TTM) | 13.5 | · | 9.1 | Fair value |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | CON | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | 16.4% | · | 11.9% | Top tier | |
| EBITDA Margin | 15.4% | · | 11.1% | Top tier | |
| Pretax Margin (TTM) | 11.7% | · | 10.3% | Top tier | |
| Net Profit Margin (TTM) | 8.7% | · | 7.3% | Top tier | |
| ROA (TTM) | 6.8% | · | 6.5% | In line | |
| ROE (TTM) | 48.5% | · | 19.1% | Top tier | |
| ROIC | 65.6% | · | 15.5% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | CON | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 1.4 | · | 1.2 | In line | |
| Quick Ratio | 1.0 | · | 0.9 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | CON | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 13.9%5Y avg ≈7.9% | ≈7.9% | · | · | |
| Revenue CAGR 3Y | 7.8% | · | · | · | |
| EPS YoY | -11.0%5Y avg ≈-6.2% | ≈-6.2% | · | · | |
| Net Income YoY | -0.08%5Y avg ≈0.13% | ≈0.13% | · | · | |
| EPS CAGR 3Y | -6.7% | · | · | · | |
| Net Income CAGR 3Y | -0.06% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | CON | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.8 | · | 0.8 | In line | |
| Receivables Turnover | 9.1 | · | 8.3 | Top tier | |
| Revenue / Employee | ≈$217.1K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Dividends Yield, payout ratio, dividend history, 5Y CAGR
Dividend Yield0.70%
Payout Ratio19.3%
Annualized Payout≈$0.25
| Ex-date | Amount | Currency | Yield |
|---|---|---|---|
| Aug 20, 2026 | $0.06 | USD | ≈0.72% |
| May 19, 2026 | $0.06 | USD | ≈0.99% |
| Mar 12, 2026 | $0.06 | USD | ≈1.1% |
| Dec 2, 2025 | $0.06 | USD | ≈1.2% |
| Aug 21, 2025 | $0.06 | USD | ≈1.1% |
| May 20, 2025 | $0.06 | USD | ≈0.84% |
| Mar 18, 2025 | $0.06 | USD | ≈0.60% |
| Nov 13, 2024 | $0.06 | USD | ≈0.31% |
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
10.4%
Next Report
Nov 04, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 6, 2026 | $0.52 | $0.42 | 22.4% |
| March 31, 2026 | $0.40 | $0.34 | 17.0% | |
| Dec. 31, 2025 | $0.28 | $0.23 | 22.1% | |
| Sept. 30, 2025 | $0.39 | $0.38 | 2.8% | |
| June 30, 2025 | $0.37 | $0.38 | -2.6% | |
| March 31, 2025 | $0.32 | $0.32 | 0.57% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $2.16B | $1.90B | $1.84B | $1.72B | |
| SG&A Expense | $203M | $156M | $152M | $150M | |
| Operating Expenses | $1.83B | $1.60B | $1.55B | $1.47B | |
| Operating Income | $334M | $305M | $288M | $259M | |
| Pretax Income | $224M | $231M | $243M | $225M | |
| Income Tax | $51M | $59M | $58M | $53M | |
| Net Income | $166M | $167M | $180M | $167M | |
| EPS (Basic) | $1.30 | $1.46 | $1.73 | $1.60 | |
| EPS (Diluted) | $1.30 | $1.46 | $1.73 | $1.60 | |
| Shares (Basic) | 126,566,000 | 114,058,000 | 104,008,000 | 103,821,000 | |
| Shares (Diluted) | 128,296,000 | 114,203,000 | 104,191,000 | 103,821,000 | |
| EBITDA | $334M | $305M | · | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $80M | $183M | $31M | · | |
| Receivables | $258M | $218M | $216M | · | |
| Prepaid Expense | $45M | $15M | · | · | |
| Other Current Assets | $43M | $35M | $39M | · | |
| Current Assets | $383M | $437M | $294M | · | |
| PP&E (Net) | · | · | $178M | · | |
| Goodwill | $1.48B | $1.23B | $1.23B | $1.23B | |
| Intangibles | $243M | $205M | $225M | · | |
| Other Non-current Assets | $20M | $7M | $8M | · | |
| Total Assets | $2.86B | $2.52B | $2.33B | $2.30B | |
| Accounts Payable | $21M | $20M | $20M | · | |
| Current Liabilities | $337M | $307M | $275M | · | |
| Capital Leases | $444M | $397M | $357M | · | |
| Deferred Tax | $49M | $25M | $23M | · | |
| Other Non-current Liabilities | $45M | $24M | $28M | · | |
| Total Liabilities | $2.44B | $2.22B | $1.16B | · | |
| Common Stock | $1M | $1M | $0 | · | |
| Retained Earnings | $146M | $14M | $685M | · | |
| AOCI | $-3M | $0 | · | · | |
| Stockholders' Equity | $393M | $276M | · | · | |
| Liabilities + Equity | $2.86B | $2.52B | $2.33B | · | |
| Shares Outstanding | 128,633,374 | 128,125,952 | · | · |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $76M | $67M | $73M | $74M | |
| Stock-based Comp | $10M | $2M | $651.0K | $2M | |
| Deferred Tax | $8M | $-4M | $-6M | $-9M | |
| Amort. of Intangibles | $26M | $22M | $30M | $29M | |
| Operating Cash Flow | $279M | $275M | $234M | $274M | |
| CapEx | $82M | $64M | $65M | $46M | |
| Investing Cash Flow | $-415M | $-71M | $-75M | $-58M | |
| Stock Repurchased | $22M | $15M | $0 | $0 | |
| Net Stock Activity | $-22M | $-15M | · | · | |
| Dividends Paid | $32M | $8M | $0 | $0 | |
| Financing Cash Flow | $32M | $-52M | $-165M | $-210M | |
| Net Change in Cash | $-103M | $152M | $-6M | $7M | |
| Taxes Paid | $46M | $56M | $61M | $42M | |
| Free Cash Flow | $197M | $210M | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | 15.4% | 16.0% | · | · | |
| Net Margin | 7.7% | 8.8% | · | · | |
| Pretax Margin | 10.3% | 12.2% | · | · | |
| EBITDA Margin | 15.4% | 16.0% | · | · | |
| ROA | 6.2% | 6.8% | · | · | |
| ROE | 49.8% | 120.8% | · | · | |
| ROIC | 65.6% | 82.1% | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.4 | · | · | |
| Quick Ratio | 1.0 | 1.3 | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.8 | · | · | |
| Receivables Turnover | 9.1 | 8.8 | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Book Value / Share | $3.06 | $2.15 | · | · | |
| Revenue / Share | $16.86 | $16.66 | · | · | |
| Cash Flow / Share | $2.18 | $2.41 | · | · | |
| Cash / Share | $0.62 | $1.43 | · | · | |
| Dividend / Share | $0.25 | $0.06 | · | · | |
| EPS (TTM) | $1.30 | $1.46 | · | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 13.9% | 3.4% | 6.6% | · | |
| Revenue CAGR 3Y | 7.8% | · | · | · | |
| EPS YoY | -11.0% | -15.6% | 8.1% | · | |
| EPS CAGR 3Y | -6.7% | · | · | · | |
| Net Income YoY | -0.08% | -7.4% | 7.9% | · | |
| Net Income CAGR 3Y | -0.06% | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $2.16B | $1.90B | · | · | |
| Net Income TTM | $166M | $167M | · | · | |
| Market Cap | $2.53B | $2.53B | · | · | |
| P/E | 15.1 | 13.5 | · | · | |
| P/S | 1.2 | 1.3 | · | · | |
| P/B | 6.4 | 9.2 | · | · | |
| P / Cash Flow | 9.1 | 9.2 | · | · | |
| P / FCF | 12.8 | 12.0 | · | · | |
| Dividend Yield | 1.3% | 0.31% | · | · | |
| Earnings Yield | 6.6% | 7.4% | · | · | |
| Payout Ratio | 19.3% | 4.8% | · | · | |
| Annual Payout | $32M | $8M | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $606M | $570M | $539M | $573M | $551M | $501M | $465M | $490M | $478M | $468M | $441M | $474M | $467M | |
| SG&A Expense | $57M | $55M | $51M | $53M | $53M | $47M | $45M | $37M | $37M | $37M | $42M | $38M | $37M | |
| Operating Expenses | $491M | $474M | $469M | $478M | $461M | $420M | $406M | $403M | $394M | $392M | $392M | $393M | $385M | |
| Operating Income | $115M | $96M | $70M | $94M | $90M | $80M | $59M | $86M | $84M | $75M | $49M | $81M | $82M | |
| Pretax Income | $89M | $70M | $43M | $66M | $61M | $54M | $33M | $62M | $71M | $65M | $39M | $70M | $71M | |
| Income Tax | $22M | $17M | $7M | $16M | $15M | $13M | $10M | $16M | $18M | $15M | $10M | $15M | $17M | |
| Net Income | $65M | $50M | $35M | $48M | $45M | $39M | $22M | $44M | $52M | $49M | $28M | $53M | $53M | |
| EPS (Basic) | $0.51 | $0.39 | $0.27 | $0.38 | $0.35 | $0.30 | $0.12 | $0.37 | $0.50 | $0.47 | $0.27 | $0.51 | $0.51 | |
| EPS (Diluted) | $0.51 | $0.39 | $0.27 | $0.38 | $0.35 | $0.30 | $0.12 | $0.37 | $0.50 | $0.47 | $0.27 | $0.51 | $0.51 | |
| Shares (Basic) | 125,102,000 | 125,781,000 | · | 126,647,000 | 126,647,000 | 126,647,000 | · | 120,765,000 | 104,094,000 | 104,094,000 | · | 104,035,000 | 103,962,000 | |
| Shares (Diluted) | 127,787,000 | 128,491,000 | · | 128,170,000 | 128,171,000 | 128,147,000 | · | 120,765,000 | 104,094,000 | 104,094,000 | · | 104,035,000 | 103,962,000 | |
| EBITDA | $115M | $96M | · | $94M | $90M | $80M | · | $86M | $84M | · | · | · | · |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $158M | $62M | $80M | $50M | $74M | $52M | $183M | $137M | $51M | · | · | · | · | |
| Receivables | $300M | $297M | $258M | $279M | $272M | $258M | $218M | $232M | $229M | · | · | · | · | |
| Prepaid Expense | $49M | $26M | $23M | $23M | $26M | · | $15M | · | · | · | · | · | · | |
| Other Current Assets | · | $45M | $43M | $42M | $44M | $40M | $35M | $31M | $39M | · | · | · | · | |
| Current Assets | $506M | $404M | $383M | $375M | $395M | $352M | $437M | $410M | $320M | · | · | · | · | |
| PP&E (Net) | · | · | · | · | · | · | · | $191M | $187M | · | · | · | · | |
| Goodwill | $1.48B | $1.48B | $1.48B | $1.48B | $1.48B | $1.44B | $1.23B | $1.23B | $1.23B | · | $1.23B | · | · | |
| Intangibles | · | · | $243M | · | · | · | $205M | · | · | · | · | · | · | |
| Other Non-current Assets | $20M | $20M | $20M | $24M | $15M | $13M | $7M | $6M | $10M | · | · | · | · | |
| Total Assets | $3.01B | $2.89B | $2.86B | $2.84B | $2.84B | $2.73B | $2.52B | $2.48B | $2.36B | · | $2.33B | · | · | |
| Accounts Payable | $36M | $32M | $21M | $33M | $39M | $35M | $20M | · | · | · | · | · | · | |
| Current Liabilities | $368M | $321M | $337M | $313M | $335M | $320M | $307M | $270M | $265M | · | · | · | · | |
| Capital Leases | $483M | $461M | $444M | $442M | $430M | $406M | $397M | $391M | $360M | · | · | · | · | |
| Deferred Tax | $47M | $48M | $49M | $37M | $24M | $24M | $25M | $22M | $22M | · | · | · | · | |
| Other Non-current Liabilities | $45M | $43M | $45M | $42M | $32M | $29M | $24M | $24M | $23M | · | · | · | · | |
| Total Liabilities | $2.50B | $2.44B | $2.44B | $2.43B | $2.47B | $2.40B | $2.22B | $2.18B | $1.09B | · | · | · | · | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | · | · | · | |
| Retained Earnings | $244M | $187M | $146M | $120M | $80M | $44M | $14M | $0 | $784M | · | · | · | · | |
| AOCI | $703.0K | $-1M | $-3M | $-4M | $-4M | $-2M | $0 | · | · | · | · | · | · | |
| Stockholders' Equity | $477M | $425M | $393M | $385M | $343M | $307M | $276M | $278M | $1.25B | · | · | · | · | |
| Liabilities + Equity | $3.01B | $2.89B | $2.86B | $2.84B | $2.84B | $2.73B | $2.52B | $2.48B | $2.36B | · | · | · | · | |
| Shares Outstanding | 127,517,736 | 127,961,780 | 128,633,374 | 128,170,202 | 128,170,952 | 128,171,952 | 128,125,952 | 127,343,503 | 104,094,000 | · | · | · | · |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $20M | $20M | $20M | $20M | $19M | $17M | $16M | $15M | $18M | $18M | $18M | $18M | $18M | |
| Stock-based Comp | $4M | $4M | $4M | $2M | $2M | $2M | $2M | $168.0K | $166.0K | $166.0K | $473.0K | $0 | · | |
| Deferred Tax | · | · | · | · | · | · | $-3M | $459.0K | · | · | $293.0K | $-3M | · | |
| Operating Cash Flow | $135M | $21M | $119M | $61M | $88M | $12M | $94M | $66M | $70M | $45M | $76M | $59M | · | |
| CapEx | $16M | $11M | $20M | $21M | $25M | $16M | $17M | $15M | $15M | $17M | $24M | $15M | · | |
| Investing Cash Flow | $-14M | $-15M | $-20M | $-20M | $-80M | $-295M | $-17M | $-17M | $-15M | $-22M | $-28M | $-15M | · | |
| Dividends Paid | $8M | $8M | $8M | $8M | $16M | $0 | $8M | $0 | · | · | · | · | · | |
| Financing Cash Flow | $-25M | $-24M | $-69M | $-64M | $13M | $152M | $-31M | $37M | $-54M | $-4M | $-40M | $-53M | · | |
| Net Change in Cash | $96M | $-18M | $30M | $-24M | $22M | $-131M | $46M | $86M | $1M | $18M | $8M | $-10M | · | |
| Taxes Paid | $35M | $-781.0K | $7M | $4M | $36M | $-48.0K | $6M | $15M | $34M | $34.0K | $11M | $18M | · | |
| Free Cash Flow | · | $10M | · | · | · | $-4M | · | · | · | · | · | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 19.0% | 16.8% | · | 16.5% | 16.3% | 16.0% | · | 17.6% | 17.6% | · | · | · | · | |
| Net Margin | 10.8% | 8.9% | · | 8.4% | 8.1% | 7.8% | · | 9.1% | 10.8% | · | · | · | · | |
| Pretax Margin | 14.7% | 12.2% | · | 11.5% | 11.1% | 10.8% | · | 12.7% | 14.9% | · | · | · | · | |
| EBITDA Margin | 19.0% | 16.8% | · | 16.5% | 16.3% | 16.0% | · | 17.6% | 17.6% | · | · | · | · | |
| ROA | 2.2% | 1.8% | · | 1.8% | 1.7% | 2.9% | · | 3.6% | 4.4% | · | · | · | · | |
| ROE | 15.9% | 13.8% | · | 14.5% | 5.6% | 25.3% | · | 31.9% | 8.3% | · | · | · | · | |
| ROIC | 18.2% | 16.9% | · | 18.6% | 19.7% | 19.7% | · | 22.9% | 5.0% | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.3 | · | 1.2 | 1.2 | 1.1 | · | 1.5 | 1.2 | · | · | · | · | |
| Quick Ratio | 1.2 | 1.1 | · | 1.1 | 1.0 | 1.0 | · | 1.4 | 1.1 | · | · | · | · |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.4 | · | 0.4 | 0.4 | · | · | · | · | |
| Receivables Turnover | 2.1 | 2.1 | · | 2.2 | 2.2 | 3.9 | · | 4.2 | 4.2 | · | · | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.74 | $3.32 | · | $3.01 | $2.67 | $2.40 | · | $2.18 | $11.98 | · | · | · | · | |
| Revenue / Share | $4.74 | $4.43 | · | $4.47 | $4.30 | $3.95 | · | $4.05 | $4.59 | · | · | · | · | |
| Cash Flow / Share | · | $0.16 | · | · | · | $0.09 | · | · | · | · | · | · | · | |
| Cash / Share | $1.24 | $0.48 | · | $0.39 | $0.58 | $0.41 | · | $1.07 | $0.49 | · | · | · | · | |
| Dividend / Share | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 | · | · | · | · | · | · | · | |
| EPS (TTM) | $1.55 | $1.39 | · | $1.15 | $1.14 | $1.29 | · | $1.61 | $1.75 | $1.76 | · | · | · |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.29B | $2.23B | · | $2.09B | $2.01B | $1.93B | · | $1.88B | $1.86B | $1.85B | · | · | · | |
| Net Income TTM | $199M | $178M | · | $153M | $149M | $156M | · | $173M | $182M | $183M | · | · | · | |
| Market Cap | $3.79B | $2.74B | · | $2.68B | $2.64B | $2.78B | · | $2.85B | · | · | · | · | · | |
| P/E | 19.2 | 15.4 | · | 18.2 | 18.0 | 16.8 | · | 13.9 | · | · | · | · | · | |
| P/S | 1.7 | 1.2 | · | 1.3 | 1.3 | 1.4 | · | 1.5 | · | · | · | · | · | |
| P/B | 8.0 | 6.5 | · | 7.0 | 7.7 | 9.1 | · | 10.3 | · | · | · | · | · | |
| P / Cash Flow | · | 130.6 | · | · | · | 237.7 | · | · | · | · | · | · | · | |
| Dividend Yield | 0.84% | 1.5% | · | 1.2% | 0.91% | · | · | · | · | · | · | · | · | |
| Earnings Yield | 5.2% | 6.5% | · | 5.5% | 5.5% | 5.9% | · | 7.2% | · | · | · | · | · | |
| Payout Ratio | 12.2% | 15.9% | · | · | · | · | · | · | · | · | · | · | · | |
| Annual Payout | $32M | $40M | · | $32M | $24M | · | · | · | · | · | · | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2024-03-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Revenue | $2.16B | $1.90B | · | $1.84B | $1.72B |
| Operating Margin % | 15.4% | 16.0% | · | · | · |
| Net Income | $166M | $167M | · | $180M | $167M |
| Diluted EPS | $1.30 | $1.46 | · | $1.73 | $1.60 |
| Metric | 2025-12-31 | 2024-12-31 | 2024-03-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.4 | · | · | · |
| Quick Ratio | 1.0 | 1.3 | · | · | · |
| Metric | 2025-12-31 | 2024-12-31 | 2024-03-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $197M | $210M | · | · | · |
Institutional owners (13F) 308 filers · $2.9B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
308
Value held
$2.9B
New positions
52
Exited positions
36
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 52 (-5 vs prior Q) | 36 (+11 vs prior Q) | 108 (+18 vs prior Q) | 82 (-6 vs prior Q) | +6.3M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| BlackRock, Inc. | $528,172,994 | 17,753,714 | 18.21% | Shares |
| VANGUARD GROUP INC | $248,046,346 | 12,603,981 | 8.55% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $202,819,316 | 6,817,456 | 6.99% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $152,611,996 | 5,129,815 | 5.26% | Shares |
| STATE STREET CORP | $143,992,945 | 4,840,099 | 4.96% | Shares |
| JENNISON ASSOCIATES LLC | $96,878,943 | 3,256,435 | 3.34% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $95,964,645 | 3,225,694 | 3.31% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $92,236,409 | 3,099,790 | 3.18% | Shares |
| Invesco Ltd. | $86,955,294 | 2,922,867 | 3.00% | Shares |
| JPMORGAN CHASE & CO | $82,937,284 | 2,780,432 | 2.86% | Shares |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | $80,400,298 | 2,702,531 | 2.77% | Shares |
| PRINCIPAL FINANCIAL GROUP INC | $78,231,604 | 2,629,375 | 2.70% | Shares |
| Woodline Partners LP | $70,504,733 | 2,369,907 | 2.43% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $55,612,508 | 1,869,328 | 1.92% | Shares |
| NORGES BANK | $50,702,717 | 1,704,293 | 1.75% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $39,075,227 | 1,313,453 | 1.35% | Shares |
| NORTHERN TRUST CORP | $39,026,050 | 1,311,800 | 1.35% | Shares |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $35,506,744 | 1,193,504 | 1.22% | Shares |
| HBK INVESTMENTS L P | $31,077,267 | 1,044,614 | 1.07% | Shares |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $30,475,365 | 1,024,382 | 1.05% | Shares |
| Bank of New York Mellon Corp | $28,135,378 | 945,727 | 0.97% | Shares |
| NEUBERGER BERMAN GROUP LLC | $27,711,293 | 931,472 | 0.96% | Shares |
| MORGAN STANLEY | $25,795,988 | 867,091 | 0.89% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $25,373,448 | 852,889 | 0.87% | Shares |
| LOOMIS SAYLES & CO L P | $24,197,549 | 813,363 | 0.83% | Shares |
| MILLENNIUM MANAGEMENT LLC | $22,313,928 | 750,048 | 0.77% | Shares |
| Nuveen, LLC | $21,582,584 | 725,465 | 0.74% | Shares |
| Tributary Capital Management, LLC | $20,563,050 | 691,195 | 0.71% | Shares |
| First Eagle Investment Management, LLC | $19,279,755 | 648,059 | 0.66% | Shares |
| BANK OF AMERICA CORP /DE/ | $18,128,133 | 609,349 | 0.62% | Shares |
| CRAMER ROSENTHAL MCGLYNN LLC | $17,446,709 | 586,444 | 0.60% | Shares |
| ROYCE & ASSOCIATES LP | $15,703,597 | 527,852 | 0.54% | Shares |
| Ceredex Value Advisors LLC | $13,707,313 | 460,750 | 0.47% | Shares |
| WELLS FARGO & COMPANY/MN | $13,364,714 | 449,234 | 0.46% | Shares |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $12,435,857 | 418,012 | 0.43% | Shares |
| Public Sector Pension Investment Board | $12,166,976 | 408,974 | 0.42% | Shares |
| ENVESTNET ASSET MANAGEMENT INC | $11,593,782 | 389,707 | 0.40% | Shares |
| GOLDMAN SACHS GROUP INC | $11,362,512 | 381,933 | 0.39% | Shares |
| PRUDENTIAL FINANCIAL INC | $10,564,433 | 355,107 | 0.36% | Shares |
| RAYMOND JAMES FINANCIAL INC | $10,014,445 | 336,620 | 0.35% | Shares |
| Russell Investments Group, Ltd. | $9,104,282 | 306,025 | 0.31% | Shares |
| JANUS HENDERSON GROUP PLC | $9,003,344 | 419,772 | 0.31% | Shares |
| RHUMBLINE ADVISERS | $8,418,337 | 282,970 | 0.29% | Shares |
| Camber Capital Management LP | $8,228,000 | 400,000 | 0.28% | Shares |
| Legal & General Group Plc | $8,172,117 | 274,693 | 0.28% | Shares |
| AMERICAN CENTURY COMPANIES INC | $8,156,736 | 274,176 | 0.28% | Shares |
| BRANT POINT INVESTMENT MANAGEMENT LLC | $7,883,750 | 265,000 | 0.27% | Shares |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | $7,810,446 | 262,536 | 0.27% | Shares |
| SIRIOS CAPITAL MANAGEMENT L P | $7,245,047 | 243,531 | 0.25% | Shares |
| Swiss National Bank | $6,903,041 | 232,035 | 0.24% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Robert A. Ortenzio ×5 filings | Sept. 1, 2026 | 5.20% | Amendment | · | SEC |
| Estate of Rocco A. Ortenzio ×2 filings | March 4, 2025 | 2.57% | Amendment | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 21 insiders · 14 officers · 7 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| William Keith Newton | Chief Executive Officer | Dec. 17, 2025 G | 89,081 | 0 | 0 | $0 |
| Matthew T. Dicanio | President & Chief Financial Officer | Nov. 26, 2025 F | 342,292 | 0 | 0 | $0 |
| Douglas R. Mcandrew | Executive Vice President, Chief Operating Officer - West | Nov. 26, 2025 F | 114,097 | 0 | 0 | $0 |
| Michael D. Rhine | Executive Vice President, Chief Operating Officer Onsite Health & Telemedicine | Nov. 26, 2025 F | 76,163 | 0 | 0 | $0 |
| Michael A. Kosuth | Executive Vice President, Chief Operating Officer - East | Nov. 26, 2025 F | 113,551 | 0 | 0 | $0 |
| Timothy F. Ryan | Executive Vice President & Chief Legal Counsel | Nov. 26, 2025 F | 114,097 | 0 | 0 | $0 |
| John Robert Anderson Jr. | Executive Vice President, Chief Medical Officer | Nov. 26, 2025 F | 113,460 | 0 | 0 | $0 |
| John A. Delorimier | Executive Vice President, Chief Digital & Data Officer | Nov. 26, 2025 F | 113,572 | 0 | 0 | $0 |
| Su Zan Nelson | Executive Vice President, Chief Accounting Officer | Nov. 26, 2025 F | 114,097 | 0 | 0 | $0 |
| Thomas A. Devasia | Executive Vice President, Chief Marketing and Innovation Officer | Nov. 26, 2025 F | 114,097 | 0 | 0 | $0 |
| Greg M. Gilbert | Executive Vice President, Chief Reimbursement & Government Relations Officer | Nov. 26, 2025 F | 114,097 | 0 | 0 | $0 |
| Danielle Kendall | Senior Vice President, Human Resources | Nov. 26, 2025 F | 76,065 | 0 | 0 | $0 |
| Jonathan P. Conser | Executive Vice President, Chief Growth & Customer Officer | Nov. 26, 2025 F | 114,097 | 0 | 0 | $0 |
| Giovanni Gallara | Executive Vice President, Chief Clinical Services Officer | Nov. 26, 2025 F | 113,437 | 0 | 0 | $0 |
| Robert A. Ortenzio | Director | Aug. 21, 2026 D | 206,286 | 0 | 4 | $-14,604,200 |
| Vipin Gopal | Director | Nov. 4, 2025 A | 15,496 | 0 | 0 | $0 |
| Marc R. Watkins | Director | Nov. 4, 2025 A | 20,740 | 0 | 0 | $0 |
| Daniel Thomas | Director | Nov. 4, 2025 A | 74,000 | 0 | 0 | $0 |
| Cheryl Pegus | Director | Nov. 4, 2025 A | 20,740 | 0 | 0 | $0 |
| Brigid A Bonner | Director | Nov. 4, 2025 A | 15,496 | 0 | 0 | $0 |
| SELECT MEDICAL CORP | 10% owner | Nov. 25, 2024 J | 0 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 78 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IDRV · iShares Trust | 3.37% | 60,800 SH | Sept. 11, 2026 | Daily |
| PSCH · Invesco Exchange-Traded Fund Trust … | 2.20% | 114,072 SH | Oct. 1, 2026 | Daily |
| XSMO · Invesco Exchange-Traded Fund Trust | 0.94% | 783,342 SH | Oct. 1, 2026 | Daily |
| JSMD · Janus Detroit Street Trust | 0.93% | 309,668 NS | July 31, 2026 | N-PORT |
| XSLV · Invesco Exchange-Traded Fund Trust … | 0.82% | 55,832 SH | Oct. 1, 2026 | Daily |
| JSML · Janus Detroit Street Trust | 0.79% | 90,994 NS | July 31, 2026 | N-PORT |
| IHF · iShares Trust | 0.60% | 228,793 SH | Sept. 11, 2026 | Daily |
| EWG · iShares, Inc. | 0.47% | 97,118 SH | Sept. 11, 2026 | Daily |
| ROSC · Lattice Strategies Trust | 0.39% | 7,651 NS | July 31, 2026 | N-PORT |
| IWO · iShares Trust | 0.26% | 1,100,276 SH | Sept. 11, 2026 | Daily |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0.26% | 17,728 SH | Oct. 1, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.21% | 126,203 SH | Aug. 19, 2026 | Daily |
| EBIT · Harbor ETF Trust | 0.20% | 772 NS | July 31, 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0.19% | 416,166 SH | Aug. 19, 2026 | Daily |
| VIOG · VANGUARD ADMIRAL FUNDS | 0.19% | 70,825 SH | Aug. 19, 2026 | Daily |
| VIOV · VANGUARD ADMIRAL FUNDS | 0.19% | 126,260 SH | Aug. 19, 2026 | Daily |
| FSMD · FIDELITY COVINGTON TRUST | 0.15% | 120,797 NS | July 31, 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0.15% | 4,191 NS | July 31, 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0.15% | 84,811 SH | Oct. 1, 2026 | Daily |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.15% | 32,177 NS | July 31, 2026 | N-PORT |
| RXI · iShares Trust | 0.14% | 4,326 SH | Sept. 11, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.14% | 111,083 SH | Oct. 1, 2026 | Daily |
| IWM · iShares Trust | 0.13% | 3,013,015 SH | Sept. 11, 2026 | Daily |
| FYT · First Trust Exchange-Traded AlphaDE… | 0.13% | 7,882 NS | July 31, 2026 | N-PORT |
| RSSL · Global X Funds | 0.12% | 56,468 NS | July 31, 2026 | N-PORT |
| EZU · iShares, Inc. | 0.12% | 138,362 SH | Sept. 11, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.11% | 678,612 SH | Aug. 19, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.09% | 421,214 NS | July 31, 2026 | N-PORT |
| EFG · iShares Trust | 0.08% | 169,180 SH | Sept. 11, 2026 | Daily |
| IVLU · iShares Trust | 0.08% | 45,809 SH | Sept. 11, 2026 | Daily |
| PXF · Invesco Exchange-Traded Fund Trust … | 0.08% | 30,664 SH | Oct. 1, 2026 | Daily |
| IQLT · iShares Trust | 0.07% | 121,549 SH | Sept. 11, 2026 | Daily |
| VBR · VANGUARD INDEX FUNDS | 0.07% | 1,676,583 SH | Aug. 19, 2026 | Daily |
| FYX · First Trust Exchange-Traded AlphaDE… | 0.07% | 29,322 NS | July 31, 2026 | N-PORT |
| TEXN · iShares Trust | 0.07% | 358 SH | Sept. 11, 2026 | Daily |
| IEV · iShares Trust | 0.06% | 12,328 SH | Sept. 11, 2026 | Daily |
| VGK · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.06% | 259,862 SH | Aug. 19, 2026 | Daily |
| IEUR · iShares Trust | 0.06% | 64,300 SH | Sept. 11, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.05% | 55,009 NS | July 31, 2026 | N-PORT |
| VYMI · VANGUARD WHITEHALL FUNDS | 0.05% | 127,647 SH | Aug. 19, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.05% | 346,728 SH | Aug. 19, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.04% | 1,364,095 SH | Aug. 19, 2026 | Daily |
| VB · VANGUARD INDEX FUNDS | 0.04% | 2,639,196 SH | Aug. 19, 2026 | Daily |
| EFA · iShares Trust | 0.04% | 377,346 SH | Sept. 11, 2026 | Daily |
| WSML · iShares Trust | 0.04% | 7,490 SH | Sept. 11, 2026 | Daily |
| IEFA · iShares Trust | 0.03% | 809,571 SH | Sept. 11, 2026 | Daily |
| DXUV · Dimensional ETF Trust | 0.03% | 5,699 NS | July 31, 2026 | N-PORT |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0.03% | 1,057,361 SH | Aug. 19, 2026 | Daily |
| VSGX · VANGUARD WORLD FUND | 0.03% | 21,879 SH | Aug. 19, 2026 | Daily |
| IDEV · iShares Trust | 0.03% | 117,436 SH | Sept. 11, 2026 | Daily |
| IMFL · Invesco Exchange-Traded Self-Indexe… | 0.03% | 3,610 SH | Oct. 1, 2026 | Daily |
| FAB · First Trust Exchange-Traded AlphaDE… | 0.03% | 1,364 NS | July 31, 2026 | N-PORT |
| ACWX · iShares Trust | 0.02% | 35,598 SH | Sept. 11, 2026 | Daily |
| IXUS · iShares Trust | 0.02% | 151,671 SH | Sept. 11, 2026 | Daily |
| VXUS · VANGUARD STAR FUNDS | 0.02% | 1,599,450 SH | Aug. 19, 2026 | Daily |
| VEU · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.02% | 253,110 SH | Aug. 19, 2026 | Daily |
| DFAC · Dimensional ETF Trust | 0.02% | 271,764 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.01% | 12,991 NS | July 31, 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.01% | 818 SH | Oct. 1, 2026 | Daily |
| DFSU · Dimensional ETF Trust | 0.01% | 7,677 NS | July 31, 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 85,961 SH | Aug. 19, 2026 | Daily |
| TOK · iShares Trust | 0.01% | 279 SH | Sept. 11, 2026 | Daily |
| DFAU · Dimensional ETF Trust | 0.01% | 36,414 NS | July 31, 2026 | N-PORT |
| URTH · iShares, Inc. | 0.01% | 8,908 SH | Sept. 11, 2026 | Daily |
| ACWI · iShares Trust | 0.01% | 32,860 SH | Sept. 11, 2026 | Daily |
| ITOT · iShares Trust | 0.01% | 164,439 SH | Sept. 11, 2026 | Daily |
| DFUV · Dimensional ETF Trust | 0.01% | 28,573 NS | July 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.01% | 37,355 NS | July 31, 2026 | N-PORT |
| IWV · iShares Trust | 0.00% | 28,294 SH | Sept. 10, 2026 | Daily |
| TILT · FlexShares Trust | 0.00% | 3,078 NS | July 31, 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 3,647,055 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 9,949 SH | Aug. 19, 2026 | Daily |
| IJR · iShares Trust | · | 7,262,708 SH | Sept. 10, 2026 | Daily |
| IJT · iShares Trust | · | 563,914 SH | Sept. 9, 2026 | Daily |
| IJS · iShares Trust | · | 530,355 SH | Sept. 8, 2026 | Daily |
| ISCB · iShares Trust | · | 5,372 SH | Sept. 11, 2026 | Daily |
| ISCV · iShares Trust | · | 26,143 SH | Sept. 11, 2026 | Daily |
| SMMV · iShares Trust | · | 9,211 SH | Sept. 1, 2026 | Daily |
CON Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 13 analysts
BUY
Median target
$40.50
+13.6%
3 23.1%
Strong Buy
9 69.2%
Buy
1 7.7%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
8 analysts · 2026-10-01Mean target $41.00 +15.0%
← Below all targets
Current price $35.65
Low$40.00
Mean$41.00
High$43.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| CON | $2.53B | 15.1 | 13.9% | 7.7% | 49.8% | · |
| THC | $17.28B | 12.8 | 3.1% | 11.1% | 56.4% | · |
| EHC | $10.61B | 19.2 | 10.5% | 9.5% | 25.1% | · |
| UHS | · | 9.4 | 9.7% | 8.6% | 21.4% | · |
| ENSG | $10.12B | 29.8 | 18.7% | 6.8% | 16.9% | · |
| PACS | $6.01B | 31.5 | 29.3% | 3.6% | 23.1% | · |
| BKD | $2.57B | -9.6 | 2.2% | -8.2% | -313.2% | 26.2% |
| ACHC | $1.28B | -1.2 | 5.0% | -33.3% | -43.9% | · |
| SNDA | $612M | -7.7 | 25.2% | -18.6% | -197.2% | · |
| SGRY | $2.00B | -25.3 | 6.2% | -2.4% | -4.5% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 6, 2026